Enovis Corporation

LSE:0I1B Stock Report

Market Cap: US$2.6b

Enovis Future Growth

Future criteria checks 1/6

Enovis is forecast to grow earnings and revenue by 88.6% and 7.4% per annum respectively. EPS is expected to grow by 101.7% per annum. Return on equity is forecast to be 6.8% in 3 years.

Key information

88.6%

Earnings growth rate

101.7%

EPS growth rate

Medical Equipment earnings growth22.5%
Revenue growth rate7.4%
Future return on equity6.8%
Analyst coverage

Good

Last updated07 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

LSE:0I1B - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,391627454410
12/31/20252,228-3121848811
12/31/20242,101-115-4125211
9/27/20242,002-121-6294N/A
6/28/20241,914-107-6071N/A
3/29/20241,817-103-3791N/A
12/31/20231,707-5413135N/A
9/29/20231,661-112-10031N/A
6/30/20231,627-159-10619N/A
3/31/20231,594-23-146-34N/A
12/31/20221,563-39-161-56N/A
9/30/20221,5531-2376N/A
7/1/20221,5305447154N/A
4/1/20221,491-109154257N/A
12/31/20211,426-103252356N/A
10/1/20211,855-48282389N/A
7/2/20212,301-18262371N/A
4/2/20212,56521222330N/A
12/31/20201,121-75187302N/A
10/2/20203,13153132238N/A
7/3/20203,17239102214N/A
4/3/20203,46042127259N/A
12/31/20193,32786131N/A
9/27/20193,0141062191N/A
6/28/20192,6922194203N/A
3/29/20192,3446674157N/A
12/31/20182,193108157226N/A
9/28/20182,492-115133205N/A
6/29/20182,813-84N/A154N/A
3/30/20183,100-92N/A176N/A
12/31/20171,93728N/A219N/A
9/29/20173,239154N/A260N/A
6/30/20173,161147N/A289N/A
3/31/20173,043151N/A272N/A
12/31/20163,186138N/A247N/A
9/30/20163,435144N/A254N/A
7/1/20163,637126N/A293N/A
4/1/20163,933138N/A321N/A
12/31/20153,434158N/A304N/A
9/25/20154,112204N/A336N/A
6/26/20154,307259N/A416N/A
3/27/20154,481397N/A451N/A
12/31/20144,624370N/A386N/A
9/26/20144,589322N/A377N/A
6/27/20144,440299N/A314N/A
3/28/20144,314160N/A309N/A
12/31/20134,207154N/A362N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 0I1B is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 0I1B is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 0I1B is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 0I1B's revenue (7.4% per year) is forecast to grow faster than the UK market (3.5% per year).

High Growth Revenue: 0I1B's revenue (7.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 0I1B's Return on Equity is forecast to be low in 3 years time (6.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y